Spots Global Cancer Trial Database for pyrotinib plus capecitabine
Every month we try and update this database with for pyrotinib plus capecitabine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE) | NCT03080805 | HER2 Positive M... | Pyrotinib Plus ... Lapatinib Plus ... | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer | NCT03691051 | HER2 Positive M... | Pyrotinib plus ... | 18 Years - | Henan Cancer Hospital |